Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Stopped early · Early Phase 1

Conditions studied: Proteinuria, Hypertension, Type II Diabetes

In brief

The purpose of this study is to determine with the administration of amiloride, observe an enhanced natriuresis, reduction in blood pressure and weight compared to the administration of hydrochlorothiazide in Type 2 Diabetics.

Key facts

Study ID

NCT01804777

Run by

University of New Mexico

People needed

9

Starts

2013-03-01

Expected to finish

2014-12-01

Last updated by the study team

2018-05-11

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of New Mexico Hospital; Clinical & Translational Science Center — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.